Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Alloreactive natural killer cells in hematopoietic stem cell transplantation.

Pegram HJ, Ritchie DS, Smyth MJ, Wiernik A, Prince HM, Darcy PK, Kershaw MH.

Leuk Res. 2011 Jan;35(1):14-21. doi: 10.1016/j.leukres.2010.07.030. Review.

PMID:
20719383
2.

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A.

Blood. 2011 Jan 20;117(3):764-71. doi: 10.1182/blood-2010-08-264085. Review.

3.

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R, Nagler A, Slavin S.

Tissue Antigens. 2004 Mar;63(3):204-11.

PMID:
14989709
4.

Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.

Chen G, Wu D, Wang Y, Cen J, Feng Y, Sun A, Tang X, Chang H, Zhu Z.

Eur J Haematol. 2008 Sep;81(3):226-35. doi: 10.1111/j.1600-0609.2008.01108.x.

PMID:
18573173
5.

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A.

Science. 2002 Mar 15;295(5562):2097-100.

6.

Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.

Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Moretta A, Sivori S.

J Leukoc Biol. 2011 Oct;90(4):661-7. doi: 10.1189/jlb.0311137. Review.

PMID:
21791599
7.

Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K, Urbani E, Negrin RS, Martelli MF, Velardi A.

Blood. 1999 Jul 1;94(1):333-9.

8.

[Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].

Chen GH, Wu DP, Sun AN, Yang MZ, Wang Y, Tang XW, Chang HR, Feng YF, Zhu ZL.

Zhonghua Xue Ye Xue Za Zhi. 2008 Aug;29(8):526-30. Chinese.

PMID:
19112915
9.

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.

Giebel S, Nowak I, Dziaczkowska J, Czerw T, Wojnar J, Krawczyk-Kulis M, Holowiecki J, Holowiecka-Goral A, Markiewicz M, Kopera M, Karolczyk A, Kyrcz-Krzemien S, Kusnierczyk P.

Eur J Haematol. 2009 Oct;83(4):343-56. doi: 10.1111/j.1600-0609.2009.01280.x.

PMID:
19500138
11.

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.

Ruggeri L, Capanni M, Mancusi A, Martelli MF, Velardi A.

Transpl Immunol. 2005 Aug;14(3-4):203-6. Review.

PMID:
15982564
12.

Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.

Moretta A, Locatelli F, Moretta L.

Immunol Rev. 2008 Aug;224:58-69. doi: 10.1111/j.1600-065X.2008.00651.x. Review.

PMID:
18759920
13.

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.

Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M.

Exp Hematol. 2003 Oct;31(10):911-23.

PMID:
14550807
14.

The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.

Kim HJ, Choi Y, Min WS, Kim TG, Cho BS, Kim SY, Eom KS, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Kim CC.

Transplantation. 2007 Nov 15;84(9):1082-91.

PMID:
17998861
15.

The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).

Keller MD, Chen DF, Condron SA, Liu N, Reinsmoen NL, Buckley RH.

J Clin Immunol. 2007 Jan;27(1):109-16. Erratum in: J Clin Immunol. 2007 Nov;27(6):659.

PMID:
17191149
16.

Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.

Moretta A, Pende D, Locatelli F, Moretta L.

Clin Exp Immunol. 2009 Sep;157(3):325-31. doi: 10.1111/j.1365-2249.2009.03983.x. Review.

17.

Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.

Kim SY, Choi HB, Yoon HY, Choi EJ, Cho B, Kim HK, Kim YJ, Kim HJ, Min CK, Kim DW, Lee JW, Min WS, Kim CC, Kim TG.

Tissue Antigens. 2007 Apr;69 Suppl 1:114-7.

PMID:
17445182
18.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.

Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.

Biol Blood Marrow Transplant. 2010 Feb;16(2):273-80. doi: 10.1016/j.bbmt.2009.10.021.

19.

Role of KIRs and KIR ligands in hematopoietic transplantation.

Velardi A.

Curr Opin Immunol. 2008 Oct;20(5):581-7. doi: 10.1016/j.coi.2008.07.004. Review.

PMID:
18675345
20.

Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.

Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A.

Cytotherapy. 2006;8(6):554-8. Review.

PMID:
17148031
Items per page

Supplemental Content

Support Center